Distributor Faces Charges Over Sale of Alleged Counterfeit Drugs

Federal efforts to protect the drug supply chain continue to bear fruit, with the FDA’s Office of Criminal Investigations announcing criminal charges for another counterfeit operation.
Source: Drug GMP Report